» Articles » PMID: 32871155

Corticotropin Releasing Factor, but Not Alcohol, Modulates Norepinephrine Release in the Rat Central Nucleus of the Amygdala

Overview
Specialties Neurology
Pharmacology
Date 2020 Sep 2
PMID 32871155
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol misuse and dependence is a widespread health problem. The central nucleus of the amygdala (CeA) plays important roles in both the anxiety associated with alcohol (ethanol) dependence and the increased alcohol intake that is observed during withdrawal in dependent animals. We and others have shown the essential involvement of the corticotropin releasing factor (CRF) system in alcohol's synaptic effects on the CeA and in the development of ethanol dependence. Another system that has been shown to be critically involved in the molecular underpinnings of alcohol dependence is the norepinephrine (NE) system originating in the locus coeruleus. Both the CRF and NE systems act in concert to facilitate a stress response: central amygdalar afferents release CRF in the locus coeruleus promoting widespread release of NE. In this study, we are the first to use fast-scan cyclic voltammetry to classify local electrically-evoked NE release in the CeA and to determine if acute alcohol and CRF modulate it. Evoked NE release is action potential dependent, is abolished after depletion of monoaminergic vesicles, differs pharmacologically from dopamine release, is insensitive to acute alcohol, and decreases in response to locally applied CRF. Taken together, these results indicate that NE release in the CeA is released canonically in a vesicular-dependent manner, and that while acute alcohol does not directly alter NE release, CRF decreases it. Our results suggest that CRF acts locally on NE terminals as negative feedback and potentially prevents hyperactivation of the CRF-norepinephrine stress pathway.

Citing Articles

Noradrenergic Mechanisms and Circuitry of Hyperkatifeia in Alcohol Use Disorder.

Varodayan F, Erikson C, Scroger M, Roberto M Biol Psychiatry. 2024; 97(6):580-589.

PMID: 39304172 PMC: 11839382. DOI: 10.1016/j.biopsych.2024.09.009.


Spatiotemporal Organization of Prefrontal Norepinephrine Influences Neuronal Activity.

Glaeser-Khan S, Savalia N, Cressy J, Feng J, Li Y, Kwan A eNeuro. 2024; 11(5.

PMID: 38702188 PMC: 11134306. DOI: 10.1523/ENEURO.0252-23.2024.


Synaptic Effects Induced by Alcohol.

Lovinger D, Roberto M Curr Top Behav Neurosci. 2023; .

PMID: 36765015 PMC: 11104446. DOI: 10.1007/7854_2022_412.


Effectiveness and Relationship between Biased and Unbiased Measures of Dopamine Release and Clearance.

Everett A, Graul B, Ronstrom J, Robinson J, Watts D, Espana R ACS Chem Neurosci. 2022; 13(10):1534-1548.

PMID: 35482592 PMC: 10763521. DOI: 10.1021/acschemneuro.2c00033.


The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder.

Varodayan F, Patel R, Matzeu A, Wolfe S, Curley D, Khom S Biol Psychiatry. 2022; 91(12):1008-1018.

PMID: 35430085 PMC: 9167785. DOI: 10.1016/j.biopsych.2022.02.006.


References
1.
Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob G . Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 1995; 15(8):5439-47. PMC: 6577636. View

2.
Reznikov L, Reagan L, Fadel J . Effects of acute and repeated restraint stress on GABA efflux in the rat basolateral and central amygdala. Brain Res. 2009; 1256:61-8. DOI: 10.1016/j.brainres.2008.12.022. View

3.
Jonsson S, Adermark L, Ericson M, Soderpalm B . The involvement of accumbal glycine receptors in the dopamine-elevating effects of addictive drugs. Neuropharmacology. 2014; 82:69-75. DOI: 10.1016/j.neuropharm.2014.03.010. View

4.
Quirarte G, Galvez R, Roozendaal B, McGaugh J . Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 1998; 808(2):134-40. DOI: 10.1016/s0006-8993(98)00795-1. View

5.
Koob G . The dark side of emotion: the addiction perspective. Eur J Pharmacol. 2015; 753:73-87. PMC: 4380644. DOI: 10.1016/j.ejphar.2014.11.044. View